Related Experiment Video
Updated: Jun 30, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
The north and south of candidemia: Issues for Latin America
Arnaldo Lopes Colombo1, Luis Thompson, John R Graybill
1Division of Infectious Diseases, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil. colomboal@terra.com.br
Abstract:
Candidemia is a growing problem in tertiary care hospitals all over the world. It is generally difficult to diagnose, leads to prolonged hospitalization, has a mortality rate of around 50% and is a financial burden to healthcare systems. The different distribution profiles of Candida species underlying candidemia seen in Latin America, North America, Canada and Europe, along with the emergence of antifungal drug resistance, make it essential to optimize regional guidelines for treating hematogenous candidiasis. This article reviews the importance of candidemia epidemiology and diagnosis from region to region and highlights the antifungal agents currently available to clinicians, comparing antifungal susceptibility profiles that dominate therapeutic strategies for candidemia in specific high-risk populations.
Related Concept Videos
Candidiasis
American Trypanosomiasis
Cryptococcal Meningitis
Fungal Phylum Microsporidia
Leishmaniasis
Antifungal Agents

